10x Genomics, Inc. (TXG)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 26.90 |
| Open | 27.02 |
| Bid | 27.52 x 300 |
| Ask | 27.68 x 300 |
| Day's range | 26.62 - 27.94 |
| 52-week range | 26.30 - 63.57 |
| Volume | |
| Avg. volume | 1,432,374 |
| Market cap | 3.288B |
| Beta (5Y monthly) | 1.89 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
3 Medical Products Stocks Set to Beat This Earnings Season
Here are three stocks, TXG, CAH and HOLX, which are expected to beat earnings estimates in the ongoing reporting cycle.
- Insider Monkey
11 Oversold MidCap Stocks To Buy Now
In this piece, we will take a look at the 11 oversold midcap stocks to buy now. If you want to skip our coverage of overbought, oversold, small cap, and mid cap stocks along with the latest stock market news, then you can skip ahead to the 5 Oversold MidCap Stocks To Buy Now. Since […]
- Zacks
Down -23.92% in 4 Weeks, Here's Why 10x Genomics (TXG) Looks Ripe for a Turnaround
10x Genomics (TXG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
© 2024 Yahoo. All rights reserved.